EX-10.1


 Exhibit 10.1 

SETTLEMENT AGREEMENT 

This Settlement Agreement (Agreement) is entered into among: (a) the United States of America, acting through the United States
Department of Justice and on behalf of the Office of Inspector General (OIG-HHS) of the Department of Health and Human Services (HHS) (collectively, the “United States”); (b) Amedisys, Inc. and Amedisys Holding, LLC (collectively,
“Amedisys”); and (c) April Nicole Brown, CAF Partners (including all individual partners of or other individuals associated with CAF Partners, each of whom individually and collectively agrees to this Agreement), Shelby L. Umberhandt,
Natalie Raven, Christy Curtis, Ellen Maffit, Brion Frix, Margaret Ognen, Malcolm Dulock, MD, and Charles H. Lewis, Jr. (collectively, “Relators”), through their authorized representatives. Hereafter, the United States, Amedisys, and
Relators are collectively referred to as the “Parties.” 
 I. RECITALS 

A. Headquartered in Baton Rouge, Louisiana, Amedisys is a for-profit national company that provides home health care services, including
nursing care and physical, speech, and occupational therapy, primarily for Medicare beneficiaries. 
 B. Pursuant to the qui tam
provisions of the False Claims Act, 31 U.S.C. § 3730(b), certain persons have filed civil actions against Amedisys, at least some of which include allegations that are encompassed by the “Covered Conduct” referenced in Paragraphs
I.D.1 through I.D.2. The civil actions enumerated in Paragraphs I.B.1 through I.B.7 are collectively referred to as the “Civil Actions.” 

  







 1. On January 22, 2010, April Nicole Brown filed a qui tam action in the United
States District Court for the Northern District of Alabama, captioned United States ex rel. April Nicole Brown v. Amedisys, Inc., Amedisys Home Health, Inc. of Alabama, original Civil Action Number CV-10-BE-0135-S (UNDER SEAL),
pursuant to the qui tam provisions of the False Claims Act, 31 U.S.C. § 3730(b). Brown filed a First Amended Complaint on or about April 5, 2012. 

2. On May 18, 2010, CAF Partners filed a qui tam action in the United States District Court for the Eastern District of
Pennsylvania captioned United States ex rel. CAF Partners and CAF Partners, individually v. Amedisys, Inc. and Ernst & Young, LLP, Civil Action Number 2-10-cv-002323 (UNDER SEAL), pursuant to the qui tam provisions of the
False Claims Act, 31 U.S.C. § 3730(b). CAF Partners filed a First Amended Complaint on or about October 27, 2010, a Second Amended Complaint on or about August 10, 2011, and a Third Amended Complaint on or about May 24, 2012.

 3. On February 15, 2011, Shelby L. Umberhandt filed a qui tam action in the United States District Court for the Northern
District of Georgia, captioned United States ex rel. Shelby L. Umberhandt, Relator, and Shelby L. Umberhandt, Plaintiff, v. Amedisys, Inc., original Civil Action Number 4 11-CV-0041-HLM (UNDER SEAL), pursuant to the qui tam provisions
of the False Claims Act, 31 U.S.C. § 3730(b). Umberhandt filed a First Amended Complaint on or about May 20, 2011.  
 4. On
March 29, 2011, Natalie Raven and Christy Curtis filed a qui tam action in the United States District Court for the Northern District of Georgia, captioned United States ex rel. Natalie Raven and Christy Curtis, State of Georgia ex
rel. Natalie Raven and Christy Curtis v. Amedisys, Inc., et al., Civil Action Number 1 11-CV-0994 (UNDER SEAL), pursuant to the qui tam provisions of the False Claims Act, 31 U.S.C. § 3730(b), and the Georgia Taxpayer Protection
False Claims Act, 23-3-120 to 23-3-127, as amended GA L. 2013, p. 141. Raven and Curtis filed a First Amended Complaint on or about November 13, 2012.  

  
 2 







 5. On June 17, 2011, Ellen Maffit and Brion Frix filed a qui tam action in the United
States District Court for the Northern District of Georgia, captioned United States ex rel. Ellen Maffit and Brion Frix, State of Georgia ex rel. Ellen Maffit and Brion Frix v. Amedisys, Inc., original Civil Action Number 1 11-CV-1976 (UNDER
SEAL), pursuant to the qui tam provisions of the False Claims Act, 31 U.S.C. § 3730(b), and the Georgia Taxpayer Protection False Claims Act, 23-3-120 to 23-3-127, as amended GA L. 2013, p. 141. 

6. On July 22, 2011, Margaret Ognen and Malcolm Dulock, MD filed a qui tam action in the United States District Court for the
Northern District of Georgia, captioned United States ex rel. Margaret Ognen and Malcolm Dulock, MD v. Amedisys, Inc., Amedisys Georgia, LLC, Amedisys Holding, LLC, Amedisys Hospice, LLC, Amedisys Northwest, LLC, Northside Hospital, Inc.
(d/b/a Northside Hospital – Forsyth), Dr. Daulton E. Todd, Jr., Daulton E. Todd, Jr., M.D., P.C., original Civil Action Number 1 11-CV-2421 (UNDER SEAL), pursuant to the qui tam provisions of the False Claims Act, 31 U.S.C.
§ 3730(b). Ognen and Dulock filed a First Amended Complaint on or about June 21, 2013, and a Second Amended Complaint on or about April 18, 2014. 

7. On March 23, 2012, Charles H. Lewis, Jr. filed a qui tam action in the United States District Court for the Western District of
New York, captioned United States, State of California, State of Colorado, State of Connecticut, State of Delaware, District of Columbia, State of Florida, State of Georgia, State of Illinois, State of


  
 3 







 
Indiana, State of Iowa, State of Louisiana, State of Maryland, Commonwealth of Massachusetts, State of Minnesota, State of New Hampshire, State of New Jersey, State of New Mexico, State of New
York, State of North Carolina, State of Oklahoma, State of Rhode Island, State of Tennessee, State of Texas, Commonwealth of Virginia, and the State of Wisconsin, ex rel. Charles H. Lewis, Jr. vs. Amedisys, Inc., original Civil Action Number 12
CV 0237 (UNDER SEAL), pursuant to the qui tam provisions of the False Claims Act, 31 U.S.C. § 3730(b), and false claims provisions enacted in each of the plaintiff states. 

C. The United States contends that Amedisys submitted or caused to be submitted claims for payment to the Medicare Program (Medicare), Title
XVIII of the Social Security Act, 42 U.S.C. §§ 1395-1395kkk-1. 
 D. 1. The United States contends that it has certain civil claims
arising from the Amedisys care centers identified in Exhibit A improperly billing and failing to refund overpayments for Medicare home health care services that Amedisys: (a) provided to non-homebound patients, (b) provided to patients
lacking a need for skilled nursing and/or skilled therapy services, (c) provided to patients without regard to medical necessity, and (d) overbilled by upcoding patients’ diagnoses, during the period from January 1, 2008 through
December 31, 2010. That conduct is referred to below as the “Primary Covered Conduct.” 
 2. The United States further
contends that it has certain civil claims arising from Amedisys’s billings to the Medicare program, during the period from April 1, 2008 through April 30, 2012, in violation of the Anti-Kickback Statute, 42 U.S.C. § 1320a-7b, and
the Stark Law, 42 U.S.C. § 1395nn, for home health services referred by 

  
 4 







 
Georgia Cancer Specialists I, PC while Amedisys was providing Georgia Cancer Specialists I, PC remuneration that was not consistent with fair market value in the form of patient care coordination
services performed by Amedisys employees. That conduct is referred to below as the “Secondary Covered Conduct.” 
 3.
Collectively, the conduct referenced in Paragraphs I.D.1 through I.D.2 is referred to as the “Covered Conduct.” 
 E. This
Agreement is neither an admission of liability by Amedisys nor a concession by the United States or the Relators that their claims are not well founded. Amedisys expressly denies the allegations of the United States and the Relators as set forth
herein and in the Civil Actions. 
 F. Relators and/or their counsel claim entitlement under 31 U.S.C. § 3730(d) to a share of the
proceeds of this Agreement and to Relators’ reasonable expenses, attorneys’ fees, and costs. Relator Shelby L. Umberhandt has a claim against Amedisys under 31 U.S.C. § 3730(h). 

G. To avoid the delay, uncertainty, inconvenience, and expense of protracted litigation of the above claims, and in consideration of the mutual
promises and obligations of this Agreement, the Parties agree and covenant as follows: 
 II. TERMS AND CONDITIONS 

1. A. In total, Amedisys agrees to pay the United States the principal sum of $150,000,000.00 (150 million dollars), plus interest accruing
thereon from October 4, 2013, at a rate of 2.25 percent per annum (collectively, the principal and interest are the “Settlement Amount”), such amount to be paid in two (2) installments as set forth in Paragraphs 1.B and C. 

  
 5 







 B. Amedisys will make a payment to the United States in the amount of $115,000,000.00 (115
million dollars), plus interest accruing thereon from October 4, 2013, at a rate of 2.25 percent per annum, within seven (7) business days after the Effective Date of this Agreement, pursuant to written instructions to be provided by the
United States. 
 C. Not later than six (6) months after the Effective Date of this Agreement, Amedisys will pay the remaining
$35,000,000 (35 million dollars), plus interest accruing thereon from October 4, 2013, at a rate of 2.25 percent per annum, pursuant to written instructions to be provided by the United States. 

2. A. Conditioned upon the United States receiving from Amedisys the payment set forth in Paragraph II.1.B, and as soon as feasible after
receipt, the United States shall pay the following by electronic funds transfer: 
 1. $5,032,696.46, plus interest accruing thereon from
October 4, 2013, at a rate of 2.25 percent per annum, to April Nicole Brown; 
 2. $14,330,584.86, plus interest accruing thereon from
October 4, 2013, at a rate of 2.25 percent per annum, to CAF Partners (collectively); 
 3. $159,743.32, plus interest accruing thereon
from October 4, 2013, at a rate of 2.25 percent per annum, to Shelby L. Umberhandt; 
 4. $358,680.76, plus interest accruing thereon
from October 4, 2013, at a rate of 2.25 percent per annum, to Natalie Raven; and 
 5. $358,680.75, plus interest accruing thereon from
October 4, 2013, at a rate of 2.25 percent per annum, to Christy Curtis. 

  
 6 







 B. Conditioned upon the United States receiving from Amedisys the payment set forth in Paragraph
II.1.C, and as soon as feasible after receipt, the United States shall pay the following by electronic funds transfer: 
 1. $ 1,531,690.23,
plus interest accruing thereon from October 4, 2013, at a rate of 2.25 percent per annum, to April Nicole Brown; 
 2. $4,361,482.35,
plus interest accruing thereon from October 4, 2013, at a rate of 2.25 percent per annum, to CAF Partners (collectively); 
 3.
$48,617.53, plus interest accruing thereon from October 4, 2013, at a rate of 2.25 percent per annum, to Shelby L. Umberhandt; 
 4.
$109,163.71, plus interest accruing thereon from October 4, 2013, at a rate of 2.25 percent per annum, to Natalie Raven; and 
 5.
$109,163.71, plus interest accruing thereon from October 4, 2013, at a rate of 2.25 percent per annum, to Christy Curtis. 
 C. Amedisys
agrees to pay Relators and Relators’ counsel in full satisfaction of their claims for expenses, attorneys’ fees, and costs under 31 U.S.C. § 3730(d) and Relator Shelby L. Umberhandt’s claim under 31 U.S.C. § 3730(h),
pursuant to separate written agreements, no later than ten (10) business days after the Effective Date of this Agreement, by electronic funds transfer pursuant to written instructions to be provided by Relators’ counsel. No other payments
shall be made by Amedisys to Relators or Relators’ counsel with respect to the matters covered by this Agreement. Relator CAF Partners (including all individual partners of or other individuals associated with CAF Partners, each of whom
individually and collectively agrees to this Agreement) represents and warrants that it has assigned and transferred all 

  
 7 







 
claims for expenses, attorneys’ fees, and costs to its counsel, Kenney & McCafferty, Durrell Law Office, and Thomas & Associates. Relator Charles H. Lewis, Jr. represents
and warrants that he has assigned and transferred all claims for expenses, attorneys’ fees, and costs to his counsel, Mueller Law, LLC and Seiger Gfeller Laurie, LLP. Relator April Nicole Brown represents and warrants that she has assigned and
transferred all claims for expenses, attorneys’ fees, and costs to her counsel, Frohsin & Barger, LLC. Relators Margaret Ognen and Malcom Dulock, MD, represent and warrant that they have assigned and transferred all claims for
expenses, attorneys’ fees, and costs to their counsel, Gorby Peters & Associates, LLC. Those claims are included in the claims being resolved through the separate written agreements referenced in this paragraph. 

3. A. Subject to the exceptions in Paragraph II.6 (concerning excluded claims), and conditioned upon Amedisys’s full payment of the
Settlement Amount, the United States releases Amedisys, together with its current and former parent corporations; direct and indirect subsidiaries; brother and sister corporations; divisions; affiliates; current and former owners; current and
former officers, directors, and employees; and the successors and assigns of any of them, from any civil or administrative monetary claim the United States has for the Primary Covered Conduct under the False Claims Act, 31 U.S.C. §§
3729-3733; the Civil Monetary Penalties Law, 42 U.S.C. § 1320a-7a; the Program Fraud Civil Remedies Act, 31 U.S.C. §§ 3801-3812; any other statute creating causes of action for civil damages or civil penalties for which the Civil
Division of the Department of Justice has actual and present authority to assert and compromise pursuant to 28 C.F.R. Part 0, Subpart I, Section 0.45(d); or the common law theories of payment by mistake, unjust enrichment, fraud, disgorgement,
conversion, and misrepresentation. 

  
 8 







 B. Subject to the exceptions in Paragraph II.6 (concerning excluded claims), and conditioned upon
Amedisys’s full payment of the Settlement Amount, the United States releases Amedisys, together with its current and former parent corporations; direct and indirect subsidiaries; brother and sister corporations; divisions; affiliates;
current and former owners; current and former officers, directors, and employees; and the successors and assigns of any of them, from any civil or administrative monetary claim the United States has for the Secondary Covered Conduct under the False
Claims Act, 31 U.S.C. §§ 3729-3733; the Civil Monetary Penalties Law, 42 U.S.C. § 1320a-7a; the Program Fraud Civil Remedies Act, 31 U.S.C. §§ 3801-3812; the Stark Law, 42 U.S.C. § 1395nn(g)(3); any other statute
creating causes of action for civil damages or civil penalties for which the Civil Division of the Department of Justice has actual and present authority to assert and compromise pursuant to 28 C.F.R. Part 0, Subpart I, Section 0.45(d); or the
common law theories of payment by mistake, unjust enrichment, fraud, disgorgement, conversion, and misrepresentation. 
 4. A. In
consideration of the obligations of Amedisys in this Agreement, and conditioned upon Amedisys’s full payment of the Settlement Amount, and full payment of the amounts identified in the separate agreements referenced in Paragraph II.2.C. above
for claims under 31 U.S.C. § 3730(d) or (h), Relators, for themselves and for their heirs, successors, attorneys, agents, and assigns, release Amedisys, its predecessors, and its current and former divisions, parents, affiliates, subsidiaries,
successors, and assigns, and their current and former directors, officers, and employees (“Amedisys Parties”) 

  
 9 







 
from any claims or allegations that Relators asserted or could have asserted, arising from the Covered Conduct and from all liability, claims, demands, actions, or causes of action whatsoever,
whether known or unknown, fixed or contingent, in law or in equity, in contract or in tort, under any federal or state statute or regulation, or in common law, that Relators would have standing to bring in any capacity as of the Effective Date of
this Agreement (“Relators’ Claims”). Relators represent and warrant that, with the exception of those claims discussed in Paragraph II.2.C for expenses, attorneys’ fees, and costs that have been assigned and transferred to
Relators’ counsel, Relators have not assigned or transferred any of Relators’ Claims to any person, entity, or thing, and Relators covenant and agree not to assert or pursue any of Relators’ Claims in any way. Relators acknowledge
that they may later discover facts different from or in addition to those which they or their attorneys now know or believe to be true. It is the intention of Relators to fully, finally, and forever settle and release all claims included in the
releases set forth herein. The releases provided herein shall remain in effect notwithstanding the discovery or existence of any additional or different facts or the occurrence of any future events, circumstances or conditions. Relators expressly
waive any and all provisions, rights, or benefits conferred by California Civil Code Section 1542 and by any law of any state or territory in the United States, or principle of common law, which is similar, comparable, or equivalent to
California Civil Code Section 1542, which provides: “A general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him or her
must have materially affected his or her settlement with the debtor.” Relators’ Claims that are released include but are not limited to any claims by Relators, Relators’ counsel, 

  
 10 







 
or the heirs, successors, attorneys, agents, or assigns of any of them against any Amedisys Parties arising from the filing of the Civil Actions or the negotiation of this Agreement or the
agreements referenced in Paragraph II.2.C above, under 31 U.S.C. § 3730(d) or (h) for expenses, attorneys’ fees, and costs. Relators and Relators’ counsel expressly reserve any claims against non-Amedisys Parties, and any
defenses related to any claims brought by non-Amedisys Parties. 
 B. Relators and their counsel further agree not to disseminate any
documents (whether in hardcopy or electronic format) in their possession or control that can be readily identified as having been created in whole or in part by, or at the direction of, Amedisys, its predecessors, or its current or former divisions,
parents, affiliates, subsidiaries, successors, or assigns, or their current or former directors, officers, or employees (“Amedisys Documents”). In this regard, Relators and their counsel will make a good faith effort to identify all such
Amedisys Documents. The obligations in this subparagraph do not apply: (1) to the extent that compliance with the obligations would conflict with a statute or regulation; (2) if disclosure of Amedisys Documents or information related
thereto is required by a subpoena or court order; (3) in the case of any Relator who is a current employee of Amedisys, but only to the degree they are authorized by Amedisys to utilize business records as necessary within the scope of their
current employment; (4) to the extent Amedisys Documents are available in the public domain; (5) to the extent Amedisys Documents or information related thereto are requested by or provided to any governmental entity, agency, or
representative, or any agent or contractor acting on behalf of a governmental entity; (6) to the extent Relators Natalie Raven and Christy Curtis or their counsel utilize documents in connection with


  
 11 







 
the case of United States ex rel. Natalie Raven and Christy Curtis, State of Georgia ex rel. Natalie Raven and Christy Curtis v. Amedisys, Inc., et al., Civil Action Number 1
11-CV-0994 (UNDER SEAL); or (7) to the extent Relators Margaret Ognen and Malcolm Dulock, MD or their counsel utilize documents in connection with the case of United States ex rel. Margaret Ognen and Malcolm Dulock, MD v. Amedisys, Inc.,
Amedisys Georgia, LLC, Amedisys Holding, LLC, Amedisys Hospice, LLC, Amedisys Northwest, LLC, Civil Action Number 1 11-CV-2421 (UNDER SEAL), as amended or re-filed, or in any state, federal or administrative action that relates to the factual
allegations contained therein. 
 C. Paragraph II.4 shall not in any way prevent Relators from disclosing any information or providing any
advice or assistance to any governmental agency or entity, representative, agent, or contractor. 
 5. A. In consideration of the
obligations of Amedisys in this Agreement and the Corporate Integrity Agreement (CIA), entered into between OIG-HHS and Amedisys, and conditioned upon Amedisys’s full payment of the Settlement Amount, OIG-HHS agrees to release and refrain from
instituting, directing, or maintaining any administrative action seeking exclusion from Medicare, Medicaid, and other Federal health care programs (as defined in 42 U.S.C. § 1320a-7b(f)) against Amedisys, including any of the Amedisys care
centers identified in Exhibit A, under 42 U.S.C. § 1320a-7a (Civil Monetary Penalties Law) or 42 U.S.C. § 1320a-7(b)(7) (permissive exclusion for fraud, kickbacks, and other prohibited activities) for the Covered Conduct, except as
reserved in Paragraph II.6 (concerning excluded claims), below, and as reserved in this Paragraph. OIG-HHS expressly reserves all rights to comply with any statutory obligations to 

  
 12 







 
exclude Amedisys from Medicare, Medicaid, and other Federal health care programs under 42 U.S.C. § 1320a-7(a) (mandatory exclusion) based upon the Covered Conduct. Nothing in this Paragraph
precludes OIG-HHS from taking action against entities or persons, or for conduct and practices, for which claims have been reserved in Paragraph II.6. 

B. Notwithstanding the foregoing, in the event Amedisys fails to pay any amount as provided in Paragraph II.1 within seven (7) business
days of the date upon which such payment is due, Amedisys shall be in Default of its payment obligations (“Default”). In the event of Default, OIG-HHS may exclude Amedisys from participating in all Federal health care programs until
Amedisys pays the Settlement Amount as set forth in Paragraph II.1 and reasonable costs. Prior to any such exclusion, OIG-HHS will provide written notice of Default to Amedisys, and Amedisys shall be given five (5) business days to cure
the Default. If Amedisys fails to cure the Default within five (5) business days of receiving written notice of Default from OIG-HHS, then OIG-HHS will provide written notice of any such exclusion to Amedisys, and Amedisys waives any further
notice of the exclusion under 42 U.S.C. § 1320a-7(b)(7), and agrees not to contest such exclusion either administratively or in any state or federal court. Reinstatement to program participation is not automatic. If at the end of the
period of exclusion Amedisys wishes to apply for reinstatement, Amedisys must submit a written request for reinstatement to OIG-HHS in accordance with the provisions of 42 C.F.R. §§ 1001.3001-3005. Amedisys will not be reinstated
unless and until OIG-HHS approves such request for reinstatement. 

  
 13 







 6. Notwithstanding the releases given in Paragraphs II.3 and II.4 of this Agreement, or any other
term of this Agreement, the following claims of the United States are specifically reserved and are not released: 
  

	 	a.	Any liability arising under Title 26, U.S. Code (Internal Revenue Code); 

  

	 	b.	Any criminal liability; 

  

	 	c.	Except as explicitly stated in this Agreement, any administrative liability, including mandatory exclusion from Federal health care programs; 


 

	 	d.	Any liability to the United States (or its agencies) for any conduct other than the Covered Conduct; 

  

	 	e.	Any liability based upon obligations created by this Agreement; 

  

	 	f.	Any liability for failure to deliver goods or services due; and 

  

	 	g.	Any liability for personal injury or property damage or for other consequential damages arising from the Covered Conduct. 


7. Relators and their heirs, successors, attorneys, agents, and assigns shall not object to this Agreement but agree and confirm that the
Agreement is fair, adequate, and reasonable under all the circumstances, and expressly waive the opportunity for a hearing on any objections to the Agreement pursuant to 31 U.S.C. § 3730(c)(2)(B). Conditioned upon receipt of the payments
described in Paragraphs II.2.A and II.2.B by April Nicole Brown, CAF Partners, Shelby L. Umberhandt, Natalie Raven, and Christy Curtis, Relators and their heirs, successors, attorneys, agents, and assigns fully and finally release, waive, and
forever discharge the United States, its agencies, officers, agents, 

  
 14 







 
employees, and servants, from any claims arising from the filing in the Civil Actions of the claims being dismissed pursuant to Paragraph II.15.A or under 31 U.S.C. § 3730, and from any
claims to a share of the proceeds of this Agreement and/or the claims in the Civil Actions being dismissed pursuant to Paragraph II.15.A. 

8. Amedisys waives and shall not assert any defenses Amedisys may have to any criminal prosecution or administrative action relating to the
Covered Conduct that may be based in whole or in part on a contention that, under the Double Jeopardy Clause in the Fifth Amendment of the Constitution, or under the Excessive Fines Clause in the Eighth Amendment of the Constitution, this Agreement
bars a remedy sought in such criminal prosecution or administrative action. Nothing in this paragraph or any other provision of this Agreement constitutes an agreement by the United States concerning the characterization of the Settlement Amount for
purposes of the Internal Revenue laws, Title 26 of the United States Code. 
 9. A. Amedisys fully and finally releases the United States,
its agencies, officers, agents, employees, and servants, from any claims (including attorneys’ fees, costs, and expenses of every kind and however denominated) that Amedisys has asserted, could have asserted, or may assert in the future against
the United States, its agencies, officers, agents, employees, and servants, related to the Covered Conduct and the United States’ investigation and prosecution thereof. 

B. In consideration of Relators’ obligations set forth in this Agreement, Amedisys, its predecessors, and its current and former
divisions, parents, affiliates, subsidiaries, successors, and assigns, and their current and former directors, officers, and employees when acting on behalf of Amedisys (collectively “the Amedisys Entities”),


  
 15 







 
fully and finally release, waive, and forever discharge each of the Relators and their respective heirs, individual partners, successors, attorneys, agents, and assigns, individually and
collectively, from any claims or allegations that the Amedisys Entities asserted or could have asserted, arising from the Covered Conduct and from all liability, claims, demands, actions, or causes of action whatsoever, whether known or unknown,
fixed or contingent, in law or in equity, in contract or in tort, under any federal or state statute or regulation, or in common law, that the Amedisys Entities would have standing to bring as of the Effective Date of this Agreement. The Amedisys
Entities acknowledge that they may later discover facts different from or in addition to those which they or their attorneys now know or believe to be true. It is the intention of the Amedisys Entities to fully, finally, and forever settle and
release all claims included in the releases set forth herein. The releases provided herein shall remain in effect notwithstanding the discovery or existence of any additional or different facts or the occurrence of any future events, circumstances
or conditions. Regarding any claims Relators or Relators’ counsel may have against non-Amedisys Parties, as reserved in Paragraph II.4.A, Amedisys reserves any related claims and defenses. 

10. The Settlement Amount shall not be decreased as a result of the denial of claims for payment now being withheld from payment by any
Medicare contractor (e.g., Medicare Administrative Contractor, fiscal intermediary, carrier) or any state payor, related to the Covered Conduct; and Amedisys agrees not to resubmit to any Medicare contractor or any state payor any previously
denied claims related to the Covered Conduct, and agrees not to appeal any such denials of claims. 

  
 16 







 11. Amedisys agrees to the following: 

a. Unallowable Costs Defined: All costs (as defined in the Federal Acquisition Regulation, 48 C.F.R. § 31.205-47; and in Titles XVIII and
XIX of the Social Security Act, 42 U.S.C. §§ 1395-1395kkk-1 and 1396-1396w-5; and the regulations and official program directives promulgated thereunder) incurred by or on behalf of Amedisys, its present or former officers, directors,
employees, shareholders, and agents in connection with: 
  

	 	(1)	the matters covered by this Agreement; 

  

	 	(2)	the United States’ audit(s) and civil investigation(s) of the matters covered by this Agreement; 

  

	 	(3)	Amedisys’s investigation, defense, and corrective actions undertaken in response to the United States’ audit(s) and civil investigation(s) in connection with the matters covered by this Agreement (including
attorney’s fees); 

  

	 	(4)	the negotiation and performance of this Agreement; 

  

	 	(5)	the payment Amedisys makes to the United States pursuant to this Agreement and any payments that Amedisys may make to Relators, including costs and attorney’s fees; and 


 

	 	(6)	the negotiation of, and obligations undertaken pursuant to the CIA to: 

  

	 	(i)	retain an independent review organization to perform reviews as described in the CIA; and 

  

	 	(ii)	prepare and submit reports to the OIG-HHS 


  
 17 







 are unallowable costs for government contracting purposes and under the Medicare Program, Medicaid Program,
TRICARE Program, and Federal Employees Health Benefits Program (FEHBP) (hereinafter referred to as Unallowable Costs). However, nothing in Paragraph II.11.a.(6) that may apply to the obligations undertaken pursuant to the CIA affects the status of
costs that are not allowable based on any other authority applicable to Amedisys. 
 b. Future Treatment of Unallowable Costs: Unallowable
Costs shall be separately determined and accounted for in nonreimbursable cost centers by Amedisys, and Amedisys shall not charge such Unallowable Costs directly or indirectly to any contracts with the United States or any State Medicaid program, or
seek payment for such Unallowable Costs through any cost report, cost statement, information statement, or payment request submitted by Amedisys or any of its subsidiaries or affiliates to the Medicare, Medicaid, TRICARE, or FEHBP Programs. 

c. Treatment of Unallowable Costs Previously Submitted for Payment: Amedisys further agrees that within 90 days of the Effective Date of this
Agreement it shall identify to applicable Medicare and TRICARE fiscal intermediaries, carriers, and/or contractors, and Medicaid and FEHBP fiscal agents, any Unallowable Costs (as defined in this Paragraph) included in payments previously sought
from the United States, or any State Medicaid program, including, but not limited to, payments sought in any cost reports, cost statements, information reports, or payment requests already submitted by Amedisys or any of its subsidiaries or
affiliates, and shall request, and agree, that such cost reports, cost statements, information reports, or payment requests, even if already settled, be adjusted to account for the effect of the inclusion of


  
 18 







 
the Unallowable Costs. Amedisys agrees that the United States, at a minimum, shall be entitled to recoup from Amedisys any overpayment plus applicable interest and penalties as a result of the
inclusion of such Unallowable Costs on previously-submitted cost reports, information reports, cost statements, or requests for payment. 

Any payments due after the adjustments have been made shall be paid to the United States pursuant to the direction of the Department of
Justice and/or the affected agencies. The United States reserves its rights to disagree with any calculations submitted by Amedisys or any of its subsidiaries or affiliates on the effect of inclusion of Unallowable Costs (as defined in this
Paragraph) on Amedisys or any of its subsidiaries or affiliates’ cost reports, cost statements, or information reports. 
 d. Nothing in
this Agreement shall constitute a waiver of the rights of the United States to audit, examine, or re-examine Amedisys’s books and records to determine that no Unallowable Costs have been claimed in accordance with the provisions of this
Paragraph. 
 12. This Agreement is intended to be for the benefit of the Parties only. The Parties do not release any claims against any
other person or entity, except to the extent provided for in Paragraph II.13 (concerning waivers for beneficiaries). 
 13. Amedisys agrees
that it waives and shall not seek payment for any of the health care billings covered by this Agreement from any health care beneficiaries or their parents, sponsors, legally responsible individuals, or third party payors based upon the claims
defined as Covered Conduct. 

  
 19 







 14. Amedisys warrants that it has reviewed its financial situation and that it currently is
solvent within the meaning of 11 U.S.C. §§ 547(b)(3) and 548(a)(1)(B)(ii)(I), and shall remain solvent following payment to the United States of the Settlement Amount. Further, the Parties warrant that, in evaluating whether to execute
this Agreement, they (a) have intended that the mutual promises, covenants, and obligations set forth constitute a contemporaneous exchange for new value given to Amedisys, within the meaning of 11 U.S.C. § 547(c)(1), and (b) conclude
that these mutual promises, covenants, and obligations do, in fact, constitute such a contemporaneous exchange. Further, the Parties warrant that the mutual promises, covenants, and obligations set forth herein are intended to and do, in fact,
represent a reasonably equivalent exchange of value that is not intended to hinder, delay, or defraud any entity to which Amedisys was or became indebted to on or after the date of this transfer, within the meaning of 11 U.S.C. § 548(a)(1).

 15. A. Upon receipt of the payments described in Paragraphs II.1 and II.2.C, above, the United States and Relators shall promptly sign
and file in the Civil Actions Joint Stipulations dismissing all claims against Amedisys, Inc.; Amedisys Holding, LLC; Amedisys Home Health, Inc. of Alabama; Amedisys Georgia, LLC; Amedisys Hospice, LLC; and Amedisys Northwest, LLC, as follows: 

 

	 	a.	the Stipulations of Dismissal shall be with prejudice as to the Relators’ claims in the Civil Actions, pursuant to and consistent with the terms and conditions of this Agreement; 


 

	 	b.	the Stipulations of Dismissal shall be with prejudice as to the United States’ claims as to the Covered Conduct, pursuant to and consistent with the terms and conditions of this Agreement; and 


  
 20 








	 	c.	the Stipulations of Dismissal shall be without prejudice as to the United States as to all claims not for the Covered Conduct, pursuant to and consistent with the terms and conditions of this Agreement.


 16. Except for Relators’ claims for expenses, attorneys’ fees, and costs under 31 U.S.C. § 3730(d) and (h),
which are being resolved pursuant to separate written agreements as provided in Paragraph II.2.C above, each Party shall bear its own legal and other costs incurred in connection with this matter, including the preparation and performance of this
Agreement. 
 17. Each Party and signatory to this Agreement represents that it freely and voluntarily enters into this Agreement without
any degree of duress or compulsion. 
 18. This Agreement is governed by the laws of the United States. The exclusive jurisdiction and venue
for any dispute relating to this Agreement is the United States District Court for the Eastern District of Pennsylvania, except for any dispute related to United States ex rel. Natalie Raven and Christy Curtis, State of Georgia ex rel. Natalie
Raven and Christy Curtis v. Amedisys, Inc., et al., Civil Action Number 1 11-CV-0994 (UNDER SEAL), for which the exclusive jurisdiction and venue is the United States District Court for the Northern District of Georgia. For purposes of
construing this Agreement, this Agreement shall be deemed to have been drafted by all Parties to this Agreement and shall not, therefore, be construed against any Party for that reason in any subsequent dispute. 

19. This Agreement constitutes the complete agreement between the Parties, except as to: (a) the separate agreements referenced in
Paragraph II.2.C above; and (b) any separate agreement(s) entered into by and among certain Relators regarding Relators’ 
 redistribution of the
United States’ payments pursuant to 31 U.S.C. § 3730(d). This Agreement may not be amended except by written consent of the Parties. 

  
 21 







 20. The undersigned counsel represent and warrant that they are fully authorized to execute this
Agreement on behalf of the persons and entities indicated below. 
 21. This Agreement may be executed in counterparts, each of which
constitutes an original and all of which constitute one and the same Agreement. 
 22. This Agreement is binding on Amedisys’s
successors, transferees, heirs, and assigns. 
 23. This Agreement is binding on Relators’ successors, transferees, heirs, and assigns.

 24. All parties consent to the United States’ disclosure of this Agreement, and information about this Agreement, to the public.

 25. This Agreement is effective on the date of signature of the last signatory to the Agreement (Effective Date of this Agreement).
Facsimiles of signatures shall constitute acceptable, binding signatures for purposes of this Agreement. 

  
 22 







 THE UNITED STATES OF AMERICA 

 

							
	DATED: 4.23.14	 		 	BY:	 	 /s/ Lisa Katz Samuels

		 		 		 	 Lisa Katz Samuels
 Trial Attorney

		 		 		 	Commercial Litigation Branch
		 		 		 	Civil Division
		 		 		 	United States Department of Justice
				
	DATED: 4.23.14	 		 	BY:	 	 /s/ Bradley Brinkman

		 		 		 	 Bradley Brinkman
 Trial Attorney

		 		 		 	Commercial Litigation Branch
		 		 		 	Civil Division
		 		 		 	United States Department of Justice


  
 23 








							
	DATED: 4.23.14	 		 	BY:	 	 /s/ Zane David Memeger

		 		 		 	Zane David Memeger
		 		 		 	United States Attorney
				
	DATED: 4.23.14	 		 	BY:	 	 /s/ Margaret L. Hutchison

		 		 		 	Margaret L. Hutchison
		 		 		 	Assistant United States Attorney
		 		 		 	Chief, Civil Division
				
	DATED: 4.23.14	 		 	BY:	 	 /s/ Gregory B. David

		 		 		 	Gregory B. David
		 		 		 	Assistant United States Attorneys
				
	DATED: 4.23.14	 		 	BY:	 	 /s/ Eric D. Gill

		 		 		 	Eric D. Gill
		 		 		 	Assistant United States Attorneys


  
 24 








							
	DATED: 04.23.14	 		 	BY:	 	 /s/ Christopher J. Huber

		 		 		 	Christopher J. Huber
		 		 		 	Assistant United States Attorney
		 		 		 	Northern District of Georgia


  
 25 








							
	DATED: 04.22.14	 		 	BY:	 	 /s/ Robert K. DeConti

		 		 		 	Robert K. DeConti
		 		 		 	Assistant Inspector General for Legal Affairs
		 		 		 	Office of Counsel to the Inspector General
		 		 		 	Office of Inspector General
		 		 		 	United States Department of Health and Human Services


  
 26 







 DEFENDANTS 
  

							
	DATED: 04.22.14	 		 	BY:	 	 /s/ Ronald A. LaBorde

		 		 		 	Ronald A. LaBorde
		 		 		 	Amedisys, Inc.
		 		 		 	Title: Interim Chief Executive Officer and President
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ Ronald A. LaBorde

		 		 		 	Ronald A. LaBorde
		 		 		 	Amedisys Holding, LLC
		 		 		 	Title: Interim Chief Executive Officer and President
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ Paul B. Murphy

		 		 		 	Paul B. Murphy, Esq.
		 		 		 	Richard L. Shackelford, Esq.
		 		 		 	Matthew H. Baughman, Esq.
		 		 		 	King & Spalding LLP


  
 27 







 RELATORS 
  

							
	DATED: 04.21.14	 		 	BY:	 	 /s/ April Nicole Brown

		 		 		 	April Nicole Brown
				
	DATED: 04.21.14	 		 	BY:	 	 /s/ James F. Barger, Jr.

		 		 		 	Henry I. Frohsin, Esq.
		 		 		 	James F. Barger, Jr., Esq.
		 		 		 	J. Elliott Walthall, Esq.
		 		 		 	Frohsin & Barger, LLC
		 		 		 	Counsel for April Nicole Brown


  
 28 








							
	DATED: 04.22.14	 		 	BY:	 	 /s/ Diane Schulman Davidow

		 		 		 	CAF Partners
		 		 		 	By: Diane Schulman Davidow
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ M. Tavy Deming, Esq.

		 		 		 	M. Tavy Deming, Esq.
		 		 		 	Emily C. Lambert, Esq.
		 		 		 	Kenney & McCafferty
		 		 		 	Counsel for CAF Partners
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ Suzanne E. Durrell, Esq.

		 		 		 	Suzanne E. Durrell, Esq.
		 		 		 	Durrell Law Office
		 		 		 	Counsel for CAF Partners
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ Robert M. Thomas, Esq.

		 		 		 	Robert M. Thomas, Esq.
		 		 		 	Thomas & Associates
		 		 		 	Counsel for CAF Partners


  
 29 








							
	DATED: 04.22.14	 		 	BY:	 	 /s/ Diane Schulman Davidow

		 		 		 	Diane Schulman Davidow
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ M. Tavy Deming, Esq.

		 		 		 	M. Tavy Deming, Esq.
		 		 		 	Emily C. Lambert, Esq.
		 		 		 	Kenney & McCafferty
		 		 		 	Counsel for Diane Schulman Davidow
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ Suzanne E. Durrell, Esq.

		 		 		 	Suzanne E. Durrell, Esq.
		 		 		 	Durrell Law Office
		 		 		 	Counsel for Diane Schulman Davidow
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ Robert M. Thomas, Esq.

		 		 		 	Robert M. Thomas, Esq.
		 		 		 	Thomas & Associates
		 		 		 	Counsel for Diane Schulman Davidow


  
 30 








							
	DATED: 04.22.14	 		 	BY:	 	 /s/ Jock Ferguson

		 		 		 	Jock Ferguson
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ M. Tavy Deming, Esq.

		 		 		 	M. Tavy Deming, Esq.
		 		 		 	Emily C. Lambert, Esq.
		 		 		 	Kenney & McCafferty
		 		 		 	Counsel for Jock Ferguson
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ Suzanne E. Durrell, Esq.

		 		 		 	Suzanne E. Durrell, Esq.
		 		 		 	Durrell Law Office
		 		 		 	Counsel for Jock Ferguson
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ Robert M. Thomas, Esq.

		 		 		 	Robert M. Thomas, Esq.
		 		 		 	Thomas & Associates
		 		 		 	Counsel for Jock Ferguson


  
 31 








							
	DATED: 04.22.14	 		 	BY:	 	 /s/ Annette Arvie

		 		 		 	Annette Arvie
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ M. Tavy Deming, Esq.

		 		 		 	M. Tavy Deming, Esq.
		 		 		 	Emily C. Lambert, Esq.
		 		 		 	Kenney & McCafferty
		 		 		 	Counsel for Annette Arvie
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ Suzanne E. Durrell, Esq.

		 		 		 	Suzanne E. Durrell, Esq.
		 		 		 	Durrell Law Office
		 		 		 	Counsel for Annette Arvie
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ Robert M. Thomas, Esq.

		 		 		 	Robert M. Thomas, Esq.
		 		 		 	Thomas & Associates
		 		 		 	Counsel for Annette Arvie


  
 32 








							
	DATED: 04.22.14	 		 	BY:	 	 /s/ Thomas A. Fisher

		 		 		 	Thomas A. Fisher
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ M. Tavy Deming, Esq.

		 		 		 	M. Tavy Deming, Esq.
		 		 		 	Emily C. Lambert, Esq.
		 		 		 	Kenney & McCafferty
		 		 		 	Counsel for Thomas A. Fisher
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ Suzanne E. Durrell, Esq.

		 		 		 	Suzanne E. Durrell, Esq.
		 		 		 	Durrell Law Office
		 		 		 	Counsel for Thomas A. Fisher
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ Robert M. Thomas, Esq.

		 		 		 	Robert M. Thomas, Esq.
		 		 		 	Thomas & Associates
		 		 		 	Counsel for Thomas A. Fisher


  
 33 








							
	DATED: 04.22.14	 		 	BY:	 	 /s/ Cynthia M. Dauner

		 		 		 	Cynthia M. Dauner
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ M. Tavy Deming, Esq.

		 		 		 	M. Tavy Deming, Esq.
		 		 		 	Emily C. Lambert, Esq.
		 		 		 	Kenney & McCafferty
		 		 		 	Counsel for Cynthia M. Dauner
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ Suzanne E. Durrell, Esq.

		 		 		 	Suzanne E. Durrell, Esq.
		 		 		 	Durrell Law Office
		 		 		 	Counsel for Cynthia M. Dauner
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ Robert M. Thomas, Esq.

		 		 		 	Robert M. Thomas, Esq.
		 		 		 	Thomas & Associates
		 		 		 	Counsel for Cynthia M. Dauner


  
 34 








							
	DATED: 04.22.14	 		 	BY:	 	 /s/ Eric D. Fader

		 		 		 	Eric D. Fader
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ M. Tavy Deming, Esq.

		 		 		 	M. Tavy Deming, Esq.
		 		 		 	Emily C. Lambert, Esq.
		 		 		 	Kenney & McCafferty
		 		 		 	Counsel for Eric D. Fader
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ Suzanne E. Durrell, Esq.

		 		 		 	Suzanne E. Durrell, Esq.
		 		 		 	Durrell Law Office
		 		 		 	Counsel for Eric D. Fader
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ Robert M. Thomas, Esq.

		 		 		 	Robert M. Thomas, Esq.
		 		 		 	Thomas & Associates
		 		 		 	Counsel for Eric D. Fader


  
 35 








							
	DATED: 04.21.14	 		 	BY:	 	 /s/ Shelby L. Umberhandt

		 		 		 	Shelby L. Umberhandt
				
	DATED: 04.21.14	 		 	BY:	 	 /s/ Kevin A. Doyle, Esq.

		 		 		 	Kevin A. Doyle, Esq.
		 		 		 	 Lokey, Mobley & Doyle LLP
 Counsel for
Shelby L. Umberhandt



  
 36 








							
	DATED: 04.22.14	 		 	BY:	 	 /s/ Natalie Raven

		 		 		 	Natalie Raven
				
	DATED: 04.21.14	 		 	BY:	 	 /s/ Louis J. Cohen

		 		 		 	Louis J. Cohen, Esq.
		 		 		 	Louis J. Cohen, P.C.
		 		 		 	Counsel for Natalie Raven
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ G. Mark Simpson

		 		 		 	G. Mark Simpson, Esq.
		 		 		 	Simpson Law Firm, LLC
		 		 		 	Counsel for Natalie Raven


  
 37 








							
	DATED: 04.22.14	 		 	BY:	 	 /s/ Christy Curtis

		 		 		 	Christy Curtis
				
	DATED: 04.21.14	 		 	BY:	 	 /s/ Louis J. Cohen

		 		 		 	Louis J. Cohen, Esq.
		 		 		 	Louis J. Cohen, P.C.
		 		 		 	Counsel for Christy Curtis
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ G. Mark Simpson

		 		 		 	G. Mark Simpson, Esq.
		 		 		 	Simpson Law Firm, LLC
		 		 		 	Counsel for Christy Curtis


  
 38 








							
	DATED: 04.22.14	 		 	BY:	 	 /s/ Ellen Maffit

		 		 		 	Ellen Maffit
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ G. Mark Simpson

		 		 		 	G. Mark Simpson, Esq.
		 		 		 	Simpson Law Firm, LLC
		 		 		 	Counsel for Ellen Maffit


  
 39 








							
	DATED: 04.22.14	 		 	BY:	 	 /s/ Brion Frix

		 		 		 	Brion Frix
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ G. Mark Simpson

		 		 		 	G. Mark Simpson, Esq.
		 		 		 	Simpson Law Firm, LLC
		 		 		 	Counsel for Brion Frix


  
 40 








							
	DATED: 04.21.14	 		 	BY:	 	 /s/ Margaret Ognen

		 		 		 	Margaret Ognen
				
	DATED: 04.21.14	 		 	BY:	 	 /s/ Mary Donne Peters

		 		 		 	Mary Donne Peters, Esq.
		 		 		 	Gorby Peters & Associates, LLC
		 		 		 	Counsel for Margaret Ognen


  
 41 








							
	DATED: 04.21.14	 		 	BY:	 	 /s/ Malcom Dulock, MD

		 		 		 	Malcolm Dulock, M.D.
				
	DATED: 04.21.14	 		 	BY:	 	 /s/ Mary Donne Peters

		 		 		 	Mary Donne Peters, Esq.
		 		 		 	Gorby Peters & Associates, LLC
		 		 		 	Counsel for Malcolm Dulock, M.D.


  
 42 








							
	DATED: 04.22.14	 		 	BY:	 	 /s/ Charles H. Lewis, Jr.

		 		 		 	Charles H. Lewis, Jr.
				
	DATED: 04.22.14	 		 	BY:	 	 /s/ William L. Hurlock

		 		 		 	William L. Hurlock, Esq.
		 		 		 	Mueller Law LLC
		 		 		 	Seiger Gfeller Laurie, LLP
		 		 		 	Counsel for Charles H. Lewis, Jr.


  
 43 







 EXHIBIT A 
  

													
	 Amedisys Care Center Name
	  	 Street Address
	  	 City
	  	State	  	Zip
Code	  	Medicare
Provider
Number	  	Amedisys
Identifier
	Amedisys Home Health, Inc. of Alabama 
d/b/a Amedisys Home Health of Ozark	  	123 S Painter Avenue, Suite C	  	Ozark	  	AL	  	36360-1802	  	01-7159	  	1030
							
	Amedisys Home Health, Inc. of Alabama 
d/b/a Amedisys Home Health of Tuscaloosa	  	1300 McFarland Blvd., NE Suite 320	  	Tuscaloosa	  	AL	  	35406-2282	  	01-7300	  	1009
							
	Amedisys Home Health, Inc. of Alabama 
d/b/a Amedisys Home Health of Fayette	  	1616 Temple Ave. N	  	Fayette	  	AL	  	35555-1319	  	01-7300	  	1015
							
	Amedisys Home Health, Inc. of Alabama 
d/b/a Amedisys Home Health of Brent	  	10341 Hwy 5, Suite E	  	Brent	  	AL	  	35034-3917	  	01-7300	  	1022
							
	 Amedisys Home Health, Inc. of Alabama
 d/b/a
Amedisys Home Health of Gadsden
	  	400 West Meighan Boulevard, Suite 200	  	Gadsden	  	AL	  	35901-3214	  	01-7305	  	1021


  
 44 








													
	 Amedisys Care Center Name
	  	 Street Address
	  	 City
	  	State	  	Zip
Code	  	Medicare
Provider
Number	  	Amedisys
Identifier
	 Amedisys Home Health, Inc. of Alabama
 d/b/a
Amedisys Home Health of Anniston
	  	171 Town Center Drive, MPS-4	  	Anniston	  	AL	  	36205-4101	  	01-7305	  	1012
							
	 Amedisys Home Health, Inc. of Alabama
 d/b/a
Amedisys Home Health of Sylacauga
	  	395 James Payton Boulevard	  	Sylacauga	  	AL	  	35150-8064	  	01-7305	  	1032
							
	 Amedisys Home Health, Inc. of Alabama
 d/b/a
Amedisys Home Health of Roanoke
	  	935 Highway 431, Unit 4	  	Roanoke	  	AL	  	36274-1736	  	01-7305	  	1033
							
	 Tender Loving Care Health Care Services of Florida, L.L.C.

d/b/a Amedisys Home Health
	  	751 Oak Street, Suite 301	  	Jacksonville	  	FL	  	32204-3376	  	10-3102	  	0467
							
	 Amedisys Florida, LLC
 d/b/a Amedisys Home
Health
	  	808 Oakfield Drive	  	Brandon	  	FL	  	33511-4949	  	10-7007	  	0412
							
	 Housecall Home Health, LLC
 d/b/a Amedisys Home
Health
	  	 700 Zeagler Dr.,

Suite 10
	  	Palatka	  	FL	  	32177-3826	  	10-8056	  	5466
							
	 Housecall Home Health, LLC
 d/b/a Amedisys Home
Health
	  	9200 NW 39th Avenue, Suite 190	  	Gainesville	  	FL	  	32606-7368	  	10-8056	  	5468


  
 45 








													
	 Amedisys Care Center Name
	  	 Street Address
	  	 City
	  	State	  	Zip
Code	  	Medicare
Provider
Number	  	Amedisys
Identifier
	 Housecall Home Health, LLC
 d/b/a Amedisys Home
Health
	  	461 SW Main Blvd.	  	Lake City	  	FL	  	32025-5268	  	10-8056	  	5478
							
	 Housecall Home Health, LLC
 d/b/a Amedisys Home
Health
	  	1541 SW 1st Avenue, Suite 102	  	Ocala	  	FL	  	34471-6506	  	10-8056	  	5439
							
	 Housecall Home Health, Inc.
 d/b/a Amedisys of
North Central Florida
	  	109 NW 3rd Avenue	  	Chiefland	  	FL	  	32626-0841	  	10-8056	  	5476
							
	 Amedisys Georgia, L.L.C.
 d/b/a Coosa Valley
Home Health, an Amedisys Company
	  	160 Three Rivers Drive, NE, Suite 1100	  	Rome	  	GA	  	30161-2306	  	11-7041	  	3320
							
	 Amedisys Georgia, L.L.C.
 d/b/a Coosa Valley
Home Health, an Amedisys Company
	  	 12 Felton Place,

Suite E
	  	Cartersville	  	GA	  	30120-2165	  	11-7041	  	3322
							
	 Amedisys Georgia, L.L.C.
 d/b/a Coosa Valley
Home Health, an Amedisys Company
	  	401 N. Main Street	  	Cedartown	  	GA	  	30125-2643	  	11-7041	  	3321


  
 46 








													
	 Amedisys Care Center Name
	  	 Street Address
	  	 City
	  	State	  	Zip
Code	  	Medicare
Provider
Number	  	Amedisys
Identifier
	 Amedisys Georgia, L.L.C.
 d/b/a Amedisys Home
Health of Covington
	  	4162 Baker Street NE	  	Covington	  	GA	  	30014-1404	  	11-7065	  	3302
							
	 Amedisys Georgia, L.L.C.
 d/b/a Amedisys Home
Health of Madison
	  	500 Great Oaks Drive, Suite 3	  	Monroe	  	GA	  	30655-8228	  	11-7065	  	3337
							
	 Amedisys Georgia, L.L.C.
 d/b/a Amedisys Home
Health of Athens
	  	1061 Dowdy Road, Suite 205	  	Athens	  	GA	  	30606-5700	  	11-7065	  	3362
							
	 Amedisys Home Health, Inc. of Alabama
 d/b/a
Amedisys Home Health of Citronelle
	  	19375 N. 3rd St, Ste 101	  	Citronelle	  	AL	  	36522-2048	  	01-7070	  	1006
							
	 Amedisys Home Health, Inc. of Alabama
 d/b/a
Amedisys Home Health of Citronelle
	  	19375 Third Street North, Suite 101	  	Citronelle	  	AL	  	35901-2048	  	01-7070	  	1025
							
	 Amedisys Louisiana, LLC
 d/b/a Amedisys Home
Health
	  	1201 Camellia Blvd., Suite 201	  	Lafayette	  	LA	  	70508-7228	  	19-7263	  	1253
							
	 Amedisys Louisiana, LLC
 d/b/a Amedisys Home
Health
	  	2341 Larkspur Lane, Suite 3	  	Opelousas	  	LA	  	70570-8664	  	19-7263	  	1292


  
 47 








													
	 Amedisys Care Center Name
	  	 Street Address
	  	 City
	  	State	  	Zip
Code	  	Medicare
Provider
Number	  	Amedisys
Identifier
	 Amedisys Mississippi, LLC
 d/b/a Amedisys Home
Health of Collins
	  	18 Melody Lane	  	Collins	  	MS	  	39428-9002	  	25-7087	  	1407
							
	 Amedisys Mississippi, LLC
 d/b/a Amedisys Home
Health of Laurel
	  	512 North 13th Ave	  	Laurel	  	MS	  	39440-3825	  	25-7087	  	1410
							
	 Amedisys Mississippi, LLC
 d/b/a Amedisys Home
Health of Hattiesburg
	  	6184 US Highway 98 West, Suite 130	  	Hattiesburg	  	MS	  	39402-8530	  	25-7087	  	1409
							
	 Amedisys Mississippi, LLC
 d/b/a Amedisys Home
Health of Magee
	  	104 1st Avenue, SE	  	Magee	  	MS	  	39111-3516	  	25-7087	  	1416
							
	 Amedisys Oklahoma, LLC
 d/b/a Amedisys Home
Health
	  	14201 Caliber Drive, Suite 110	  	Oklahoma City	  	OK	  	73134-1027	  	37-7642	  	2038
							
	 Amedisys Oklahoma, LLC
 d/b/a Amedisys Home
Health
	  	404 West Main St	  	Stroud	  	OK	  	74079-3614	  	37-7642	  	2043
							
	 Amedisys Oklahoma, LLC
 d/b/a Amedisys Home
Health
	  	2209 Boren Boulevard	  	Seminole	  	OK	  	74868-1927	  	37-7642	  	2042
							
	 Amedisys Oklahoma, LLC
 d/b/a Amedisys Home
Health
	  	427 E. Cherokee Ave, Suite 3	  	Enid	  	OK	  	73701-5823	  	37-7642	  	2040


  
 48 








													
	 Amedisys Care Center Name
	  	 Street Address
	  	 City
	  	State	  	Zip
Code	  	Medicare
Provider
Number	  	Amedisys
Identifier
	 Amedisys Oklahoma, LLC
 d/b/a Amedisys Home
Health
	  	1609 N. Strong Blvd, Suite 200	  	McAlester	  	OK	  	74501-3881	  	37-7642	  	2041
							
	 Amedisys Oklahoma, LLC
 d/b/a Amedisys Home
Health
	  	424 S. Mustang Road, Suite A	  	Yukon	  	OK	  	73099-7315	  	37-7642	  	2039
							
	 Amedisys Oklahoma, LLC
 d/b/a Amedisys Home
Health
	  	1212 Merrick Dr.	  	Ardmore	  	OK	  	73401-1824	  	37-7642	  	2044
							
	 Amedisys Pennsylvania, L.L.C.
 d/b/a Amedisys
Home Health
	  	620 Freedom Business Center, Suite 100	  	King of Prussia	  	PA	  	19406-1330	  	39-7780	  	2623
							
	 Amedisys Pennsylvania, L.L.C.
 d/b/a Amedisys
Home Health
 1605 N. Cedar Crest Blvd
	  	1605 N. Cedar Crest Blvd, Suite 509	  	Allentown	  	PA	  	18104-2355	  	39-7780	  	2625
							
	 Amedisys SC, L.L.C.
 d/b/a Amedisys Home Health
of Lexington
	  	714 South Lake Drive, Suite 250	  	Lexington	  	SC	  	29072-3433	  	42-7039	  	2211
							
	 Amedisys SC, L.L.C.
 d/b/a Amedisys Home Health
of Orangeburg
	  	1704 Village Park Drive	  	Orangeburg	  	SC	  	29118-2401	  	42-7039	  	2213


  
 49 








													
	 Amedisys Care Center Name
	  	 Street Address
	  	 City
	  	State	  	Zip
Code	  	Medicare
Provider
Number	  	Amedisys
Identifier
	 Amedisys SC, L.L.C.
 d/b/a Amedisys Home Health
of Sumter
	  	3481 Declaration Blvd	  	Sumter	  	SC	  	29154-8140	  	42-7039	  	2214
							
	 Amedisys SC, L.L.C.
 d/b/a Amedisys Home Health
of Newberry
	  	184 Commerce Dr.	  	Newberry	  	SC	  	29108-2964	  	42-7039	  	2212
							
	 Amedisys Home Health, Inc. of South Carolina

d/b/a Amedisys Home Health of Greenville
	  	440 Roper Mountain Road, Suite G-1	  	Greenville	  	SC	  	29615-4235	  	42-7116	  	2223
							
	 Amedisys Home Health, Inc. of South Carolina

d/b/a Amedisys Home Health of Clinton
	  	210 Physicians Park Dr, Suite U	  	Clinton	  	SC	  	29325-7563	  	42-7116	  	2204
							
	 Amedisys Tennessee, LLC
 d/b/a Amedisys Home
Health
	  	100 Physicians Way, Suite 240	  	Lebanon	  	TN	  	37090-8108	  	44-7206	  	0507
							
	 Amedisys Tennessee, LLC
 d/b/a Amedisys Home
Health
	  	230 Cumberland Bend, Suite D	  	Nashville	  	TN	  	37228-1804	  	44-7206	  	0506
							
	 Amedisys Tennessee, LLC
 d/b/a Amedisys Home
Health
	  	880 Greenlea Blvd, Suite A	  	Gallatin	  	TN	  	37066-3282	  	44-7206	  	0508


  
 50 








													
	 Amedisys Care Center Name
	  	 Street Address
	  	 City
	  	State	  	Zip
Code	  	Medicare
Provider
Number	  	Amedisys
Identifier
	 Amedisys Tennessee, LLC
 d/b/a Amedisys Home
Health
	  	2690 Madison Street, Suite 200	  	Clarksville	  	TN	  	37043-5498	  	44-7206	  	0532
							
	 Amedisys Tennessee, LLC
 d/b/a Amedisys Home
Health
	  	437 Henslee Drive	  	Dickson	  	TN	  	37055-2166	  	44-7206	  	0528
							
	 Amedisys Tennessee, LLC
 d/b/a Amedisys Home
Health
	  	342 W. Central Avenue	  	Jamestown	  	TN	  	38556-3407	  	44-7260	  	0530
							
	 Amedisys Tennessee, LLC
 d/b/a Amedisys Home
Health
	  	508 West Main Street	  	Livingston	  	TN	  	38570-1718	  	44-7260	  	0523
							
	 Amedisys Tennessee, LLC
 d/b/a Amedisys Home
Health
	  	236 Miller Avenue, Suite 102	  	Crossville	  	TN	  	38555-4036	  	44-7260	  	0533
							
	 Amedisys Tennessee, LLC
 d/b/a Amedisys Home
Health
	  	20039 Alberta St, Suite D	  	Oneida	  	TN	  	37841-3501	  	44-7260	  	0531
							
	 Amedisys Tennessee, LLC
 d/b/a Amedisys Home
Health
	  	315 N. Washington Ave, Suite 255	  	Cookeville	  	TN	  	38501-2697	  	44-7260	  	0544
							
	 HHC, Inc.
 d/b/a Amedisys Home Health
Care
	  	 6645 Stage Rd,

Suite 102
	  	Bartlett	  	TN	  	38134-3828	  	44-7451	  	5509
							
	 Amedisys Home Health, Inc. of Virginia
 d/b/a
Amedisys Home Health Care
	  	16009 Porterfield Highway	  	Abingdon	  	VA	  	24210-8471	  	49-7566	  	1703


  
 51 








													
	 Amedisys Care Center Name
	  	 Street Address
	  	 City
	  	State	  	Zip
Code	  	Medicare
Provider
Number	  	Amedisys
Identifier
	 Amedisys Home Health, Inc. of Virginia
 d/b/a
Amedisys Home Health of Duffield
	  	372 Technology Trail Lane, Suite 103	  	Duffield	  	VA	  	24244-5330	  	49-7566	  	1702
							
	 Amedisys Home Health, Inc. of Virginia
 d/b/a
Amedisys Home Health of Clintwood
	  	909 West Main Street, Suite B	  	Clintwood	  	VA	  	24228-2130	  	49-7566	  	1709


  
 52